Study Finds Optimal Method For Prostate Volume Measurement in PI-RADS
Prostate volume and PSA density (PSAd) are important in the risk stratification of suspected prostate cancer (Pca). In a study, researchers have found that the segmentation method for PSA density outperforms the traditional ellipsoid method for high-grade cancer. The study findings were published online in the journal Clinical Imaging on September 20, 2021.
Prostate volume plays an important role in the workup of suspected prostate cancer in addition to disease management. Traditionally, prostate volume was assessed by using ellipsoid measurements on ultrasound. However, this has been found to be user-dependent and has poor reproducibility. Prostate Imaging Reporting & Data System (PI-RADS) v2.1 allows for determining volume via segmentation or ellipsoid calculation. To further examine the ellipsoid and segmentation volume calculation methods, Dr Kiran R. Nandalur and his team conducted a study and evaluated if PSAd diagnostic performance is altered with ellipsoid and segmentation volume calculation methods.
In a retrospective study, the researchers included 397 men who underwent MRI and had recent pathology, with subset analysis of grade group 2 and higher and grade group 4 and higher. They determined prostate total volumes using ellipsoid calculations (TVe) and with semi-automated segmentation (TVs), along with inter-rater reliability with intraclass correlation coefficient (ICC). They calculated PSAd for TVe and created TVs and ROC curves to compare performance for Gleason ≥3 + 4 and ≥4 + 4 diseases.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.